Metropolitan Life Insurance Company (MetLife)’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,743
| Closed | -$16.2K | – | 2075 |
|
|
2024
Q1 | $16.2K | Hold |
1,743
| – | – | ﹤0.01% | 1957 |
|
|
2023
Q4 | $14.7K | Hold |
1,743
| – | – | ﹤0.01% | 2044 |
|
|
2023
Q3 | $13.5K | Hold |
1,743
| – | – | ﹤0.01% | 2079 |
|
|
2023
Q2 | $20K | Buy |
+1,743
| New | +$20K | ﹤0.01% | 1932 |
|
|
2020
Q4 | – | Sell |
-9,048
| Closed | -$96.5K | – | 2574 |
|
|
2020
Q3 | $96.5K | Hold |
9,048
| – | – | ﹤0.01% | 2239 |
|
|
2020
Q2 | $114K | Hold |
9,048
| – | – | ﹤0.01% | 2176 |
|
|
2020
Q1 | $82.8K | Hold |
9,048
| – | – | ﹤0.01% | 2153 |
|
|
2019
Q4 | $126K | Hold |
9,048
| – | – | ﹤0.01% | 2191 |
|
|
2019
Q3 | $156K | Hold |
9,048
| – | – | ﹤0.01% | 2048 |
|
|
2019
Q2 | $246K | Hold |
9,048
| – | – | ﹤0.01% | 1758 |
|
|
2019
Q1 | $173K | Hold |
9,048
| – | – | ﹤0.01% | 1996 |
|
|
2018
Q4 | $85.1K | Hold |
9,048
| – | – | ﹤0.01% | 2364 |
|
|
2018
Q3 | $171K | Hold |
9,048
| – | – | ﹤0.01% | 2111 |
|
|
2018
Q2 | $177K | Buy |
9,048
+3,157
| +54% | +$61.7K | ﹤0.01% | 2029 |
|
|
2018
Q1 | $111K | Hold |
5,891
| – | – | ﹤0.01% | 2242 |
|
|
2017
Q4 | $98K | Sell |
5,891
-5,192
| -47% | -$86.4K | ﹤0.01% | 2319 |
|
|
2017
Q3 | $228K | Buy |
+11,083
| New | +$228K | ﹤0.01% | 2206 |
|